Swollen Knee Treatment Market Research Report – Forecast to 2027

Swollen Knee Treatment Market: By Type (Medications- Corticosteroids, Patient-controlled analgesia pumps, Surgery- Arthrocentesis, Arthroscopy, Knee replacement, and Others), End-User (Hospitals, Clinics, and Others) -Forecast Till 2027

ID: MRFR/Pharma/4945-HCR | | Region : Global

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Swollen Knee Treatment Market, by Type

6.1 Introduction

6.2 Medications

6.2.1 Corticosteroids

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.2 Opioids

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.2 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Patient-controlled analgesia (PCA) pumps

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Nerve blocks

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 Liposomal bupivacaine

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 Surgery

6.5.1 Arthrocentesis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5.2 Arthroscopy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5.3 Knee replacement

6.5.1.1 Total knee replacement

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5.1.2 Uni-compartmental knee replacement

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5.1.3 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Swollen Knee Treatment Market, by End-User

7.1 Introduction

7.2 Hospitals

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Clinics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Ambulatory Surgery Centers

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Swollen Knee Treatment, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Stryker Corporation

10.1.1 Company Overview

10.1.2 Type Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Zimmer Holdings

10.2.1 Company Overview

10.2.2 Type Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Smith & Nephew Plc.

10.3.1 Company Overview

10.3.2 Type Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 DePuy Companies Inc.

10.4.1 Company Overview

10.4.2 Technology/Business Segment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Wright Medical Group Inc.

10.5.1 Company Overview

10.5.2 Type Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Biomet Inc.

10.6.1 Company Overview

10.6.2 Type Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Exactech

10.7.1 Overview

10.7.2 Type Overview

10.7.3 Financial Overview

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 B. Braun Melsungen AG

10.8.1 Overview

10.8.2 Type/ Technology Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Pfizer Pharmaceuticals, Inc.

10.9.1 Overview

10.9.2 Type Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 Merck & Co.

10.10.1 Overview

10. 10.2 Type Overview

10. 10.3 Financials

10. 10.4 Key Developments

10. 10.5 SWOT Analysis

10.11 Fresenius Kabi

10.11.1 Overview

10. 11.2 Type Overview

10. 11.3 Financials

10. 11.4 Key Developments

10. 11.5 SWOT Analysis

10.12 AngioDynamics

10.12.1 Overview

10.12.2 Type Overview

10.12.3 Financials

10.12.4 Key Developments

10.12.5 SWOT Analysis

10.13 C.R.Bard

10.13.1 Overview

10.13.2 Type Overview

10.13.3 Financials

10.13.4 Key Developments

10.13.5 SWOT Analysis

10.14 Teleflex

10.14.1 Overview

10.14.2 Type Overview

10.14.3 Financials

10.14.4 Key Developments

10.14.5 SWOT Analysis

10.15 Smiths Medical

10.15.1 Overview

10.15.2 Type Overview

10.15.3 Financials

10.15.4 Key Developments

10.15.5 SWOT Analysis

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s Viewpoint

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the Biosurgery Industry

Chapter 12. Appendix

LIST OF TABLES

Table 1 Global Swollen Knee Treatment Synopsis, 2020–2027

Table 2 Global Swollen Knee Treatment Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Swollen Knee Treatment, by Region, 2020–2027 (USD Million)

Table 4 Global Swollen Knee Treatment, by Type, 2020–2027 (USD Million)

Table 6 Global Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)

Table 7 North America: Swollen Knee Treatment, by Type, 2020–2027 (USD

Million)

Table 8 North America: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)

Table 9 US: Swollen Knee Treatment, by Type, 2020–2027 (USD Million)

Table 10 US: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)

Table 11 Canada: Swollen Knee Treatment, by Type, 2020–2027 (USD Million)

Table 12 Canada Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)

Table 13 South America: Swollen Knee Treatment, by Type, 2020–2027 (USD

Million)

Table 14 South America: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)

Table 15 Europe: Swollen Knee Treatment, by Type, 2020–2027 (USD Million)

Table 16 Europe: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)

Table 17 Western Europe: Swollen Knee Treatment, by Type, 2020–2027 (USD

Million)

Table 18 Western Europe: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)

Table 19 Eastern Europe: Swollen Knee Treatment, by Type, 2020–2027 (USD

Million)

Table 20 Eastern Europe: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)

Table 21 Asia-Pacific: Swollen Knee Treatment, by Type, 2020–2027 (USD

Million)

Table 22 Asia-Pacific: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)

Table 23 Middle East & Africa: Swollen Knee Treatment, by Type, 2020–2027

(USD Million)

Table 24 Middle East & Africa Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Swollen Knee Treatment

Figure 3 Segmentation Market Dynamics for Global Swollen Knee Treatment

Figure 4 Global Swollen Knee Treatment Share, by Type, 2020

Figure 5 Global Swollen Knee Treatment Share, by Structure, 2020

Figure 6 Global Swollen Knee Treatment Share, by Application, 2020

Figure 7 Global Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)

Figure 8 Global Swollen Knee Treatment Share, by Region, 2020

Figure 9 North America: Swollen Knee Treatment Share, by Country, 2020

Figure 10 Europe: Swollen Knee Treatment Share, by Country, 2020

Figure 11 Asia-Pacific: Swollen Knee Treatment Share, by Country, 2020

Figure 12 Middle East & Africa: Swollen Knee Treatment Share, by Country, 2020

Figure 13 Global Swollen Knee Treatment: Company Share Analysis, 2020 (%)

Figure 14 Stryker Corporation: Key Financials

Figure 15 Stryker Corporation: Segmental Revenue

Figure 16 Stryker Corporation: Geographical Revenue

Figure 17 Zimmer Holdings: Key Financials

Figure 18 Zimmer Holdings: Segmental Revenue

Figure 19 Zimmer Holdings: Geographical Revenue

Figure 20 Smith & Nephew Plc.: Key Financials

Figure 21 Smith & Nephew Plc.: Segmental Revenue

Figure 22 Smith & Nephew Plc.: Geographical Revenue

Figure 23 DePuy Companies, Inc.: Key Financials

Figure 24 DePuy Companies, Inc.: Segmental Revenue

Figure 25 DePuy Companies, Inc.: Geographical Revenue

Figure 26 Wright Medical Group Inc.: Key Financials

Figure 27 Wright Medical Group Inc.: Segmental Revenue

Figure 28 Wright Medical Group Inc.: Geographical Revenue

Figure 27 Biomet Inc.: Key Financials

Figure 30 Biomet Inc.: Segmental Revenue

Figure 31 Biomet Inc.: Geographical Revenue

Figure 32 Exactech: Key Financials

Figure 33 Exactech: Segmental Revenue

Figure 34 Exactech: Geographical Revenue

Figure 35 B. Braun Melsungen AG: Key Financials

Figure 36 B. Braun Melsungen AG: Segmental Revenue

Figure 37 B. Braun Melsungen AG: Geographical Revenue

Figure 38 Pfizer Pharmaceuticals Inc.: Key Financials

Figure 37 Pfizer Pharmaceuticals Inc.: Segmental Revenue

Figure 40 Pfizer Pharmaceuticals Inc.: Geographical Revenue

Figure 41 Merck & Co.: Key Financials

Figure 42 Merck & Co.: Segmental Revenue

Figure 43 Merck & Co.: Geographical Revenue

Figure 44 Fresenius Kabi: Key Financials

Figure 45 Fresenius Kabi: Segmental Revenue

Figure 46 Fresenius Kabi: Geographical Revenue

Figure 47 AngioDynamics: Key Financials

Figure 48 AngioDynamics: Segmental Revenue

Figure 47 AngioDynamics: Geographical Revenue

Figure 50 C.R.Bard: Key Financials

Figure 51 C.R.Bard: Segmental Revenue

Figure 52 C.R.Bard: Geographical Revenue

Figure 53 Teleflex: Key Financials

Figure 54 Teleflex: Segmental Revenue

Figure 55 Teleflex: Geographical Revenue

Figure 56 Smiths Medical: Key Financials

Figure 57 Smiths Medical: Segmental Revenue

Figure 58 Smiths Medical: Geographical Revenue